Trial Profile
Efficacy of Intermittent Tiotropium in Early Childhood Wheezing
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Feb 2021
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary) ; Fluticasone furoate; Salbutamol sulfate
- Indications Dyspnoea; Wheezing
- Focus Therapeutic Use
- 26 Nov 2020 Status changed from active, no longer recruiting to completed.
- 01 Feb 2020 Status changed from recruiting to active, no longer recruiting.
- 08 Mar 2016 New trial record